COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 184 filers reported holding COHERUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,498,000 | -49.1% | 116,069 | -37.1% | 0.00% | -50.0% |
| Q4 2021 | $2,945,000 | -8.5% | 184,504 | -7.8% | 0.00% | 0.0% |
| Q3 2021 | $3,217,000 | +58.6% | 200,171 | +36.5% | 0.00% | +100.0% |
| Q2 2021 | $2,028,000 | +62.6% | 146,603 | +71.8% | 0.00% | 0.0% |
| Q1 2021 | $1,247,000 | -34.7% | 85,357 | -22.3% | 0.00% | 0.0% |
| Q4 2020 | $1,909,000 | -16.0% | 109,859 | -11.3% | 0.00% | -50.0% |
| Q3 2020 | $2,273,000 | +72.1% | 123,917 | +67.5% | 0.00% | +100.0% |
| Q2 2020 | $1,321,000 | -51.2% | 73,963 | -55.7% | 0.00% | -50.0% |
| Q1 2020 | $2,708,000 | +110.7% | 166,931 | +134.0% | 0.00% | +100.0% |
| Q4 2019 | $1,285,000 | -13.3% | 71,343 | -2.5% | 0.00% | 0.0% |
| Q3 2019 | $1,482,000 | -29.2% | 73,171 | -22.7% | 0.00% | -50.0% |
| Q2 2019 | $2,093,000 | +1343.4% | 94,688 | +815.4% | 0.00% | – |
| Q2 2018 | $145,000 | -39.6% | 10,344 | -52.4% | 0.00% | – |
| Q1 2018 | $240,000 | +36.4% | 21,733 | +8.9% | 0.00% | – |
| Q4 2017 | $176,000 | – | 19,950 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |